Fish & Richardson

John Adkisson Re-Elected to Second Term as President & CEO of Fish & Richardson

Retrieved on: 
Monday, March 4, 2024

John Adkisson has been re-elected to serve a second four-year term as president & CEO of Fish & Richardson, a global intellectual property law firm with 14 offices in the U.S., China, and Germany.

Key Points: 
  • John Adkisson has been re-elected to serve a second four-year term as president & CEO of Fish & Richardson, a global intellectual property law firm with 14 offices in the U.S., China, and Germany.
  • View the full release here: https://www.businesswire.com/news/home/20240304858974/en/
    Fish & Richardson President & CEO John Adkisson (Photo: Business Wire)
    “Fish is distinguished by our unparalleled client representation, technical expertise, and people-first culture.
  • I am honored that my colleagues have entrusted me to continue leading the firm forward,” said Adkisson.
  • “Thanks to the resilience of our people, Fish flourished and emerged from the pandemic stronger and more adaptable,” said Adkisson.

Fish & Richardson Expands Life Sciences Industry Team with Addition of Louis Fogel and Shaun Van Horn

Retrieved on: 
Wednesday, February 28, 2024

Intellectual property law firm Fish & Richardson is pleased to welcome seasoned litigators Louis Fogel, Ph.D., and Shaun Van Horn.

Key Points: 
  • Intellectual property law firm Fish & Richardson is pleased to welcome seasoned litigators Louis Fogel, Ph.D., and Shaun Van Horn.
  • The pair, who are based in Chicago, join Fish’s Litigation Group and are members of the Life Sciences Industry Team.
  • View the full release here: https://www.businesswire.com/news/home/20240228410387/en/
    Fish & Richardson Principal Louis Fogel (Photo: Business Wire)
    “Louis and Shaun have an impressive record and deep market knowledge in life sciences litigation,” said Global Head of Litigation Corrin Drakulich.
  • “Fish has been a dominant force in life sciences litigation for decades, and I’m thrilled to join this distinguished group,” said Fogel.

Leading Intellectual Property Law Firm Fish & Richardson Launches Team Focused on Protecting Life Sciences Innovations

Retrieved on: 
Monday, February 12, 2024

Fish & Richardson has appointed leading trial attorney Martina Hufnal and veteran patent prosecutor Todd Garcia , Ph.D. to chair the firm’s Life Sciences Industry Team.

Key Points: 
  • Fish & Richardson has appointed leading trial attorney Martina Hufnal and veteran patent prosecutor Todd Garcia , Ph.D. to chair the firm’s Life Sciences Industry Team.
  • The team represents every sector of the life sciences market, including pharmaceutical, medical device, medtech and biotech companies, as well as academic and research institutions.
  • "Fish has a nationally recognized bench of trial attorneys and IP practitioners whose experience representing life sciences companies is second to none,” said Fish President and CEO John Adkisson .
  • Fish attorneys are experienced in each sector of the life sciences market, including small molecule, large molecule, medical device, medtech, and biotech.

Lex Machina Releases 2024 Patent Litigation Report

Retrieved on: 
Thursday, February 8, 2024

MENLO PARK, Calif., Feb. 8, 2024 /PRNewswire/ -- Lex Machina, a LexisNexis company, today releases its annual Patent Litigation Report. The report examines trends in patent litigation in federal district courts, appellate courts, and the Patent Trial and Appeal Board (PTAB). Focusing on the three-year period from 2021 to 2023, it surveys emerging trends in case filings, venues, judges, law firms, parties, timing metrics, case resolutions, findings, and damages. The report often focuses on different sets of data, e.g., filtering cases in order to provide analytics on general patent, high-volume plaintiff, ANDA, PTAB, and federal appellate cases.

Key Points: 
  • Patent case filings continued the decreasing trend exhibited since 2021, likely driven by the drop in cases filed by high-volume plaintiffs over the same period of time, and case filings before Judge Albright and the Western District of Texas declined in 2023
    MENLO PARK, Calif., Feb. 8, 2024 /PRNewswire/ -- Lex Machina, a LexisNexis company, today releases its annual Patent Litigation Report.
  • The report examines trends in patent litigation in federal district courts, appellate courts, and the Patent Trial and Appeal Board (PTAB).
  • "Our data illuminates several intriguing recent trends in patent litigation," said Elaine Chow, Lex Machina's patent legal data expert and editor of the report.
  • Register here for a copy of the report: https://pages.lexmachina.com/2024-Patent-Report_LP.html
    Lex Machina is hosting a webcast to discuss the report on February 8, 2024 at noon ET/9am PT with Michael Connelly (President of WIT Legal), Michael Flynn (Partner at Morris Nichols Arsht & Tunnell), Elaine Chow (Lex Machina's Legal Data Expert in Patent Litigation), and Aria Nejad (Lex Machina's in-house counsel).

Former Administrative Patent Judge and Associate Solicitor Kristi L.R. Sawert, Ph.D., Joins Fish & Richardson, Expanding Post-Grant Practice and Life Science Focus

Retrieved on: 
Monday, January 22, 2024

Today former U.S. Patent Trial and Appeal Board Administrative Patent Judge and Associate Solicitor Kristi L.R.

Key Points: 
  • Today former U.S. Patent Trial and Appeal Board Administrative Patent Judge and Associate Solicitor Kristi L.R.
  • As a principal, Dr. Sawert will focus her experience on representing life sciences clients, particularly in biotechnology and pharmaceuticals.
  • “Kristi brings a rare and valuable combination of law firm and government experience to Fish,” said John Adkisson, Fish president & chief executive officer.
  • “During my tenure as an administrative patent judge, I had the opportunity to see firsthand the impressive professionalism, preparedness, and skill of Fish attorneys,” said Sawert.

Blank Rome Bolsters IP Litigation Practice with Addition of Partner Andrew Kopsidas in Washington, D.C.

Retrieved on: 
Thursday, January 4, 2024

He joins Blank Rome from Hughes Hubbard & Reed and previously practiced at Fish & Richardson for more than 20 years.

Key Points: 
  • He joins Blank Rome from Hughes Hubbard & Reed and previously practiced at Fish & Richardson for more than 20 years.
  • The firm has experienced strategic growth in its IP practice over the past 18 months, adding 12 partners, associates, and patent agents.
  • Blank Rome has earned a national reputation for its IP capabilities and the expanded team enhances the firm’s deep bench of IP attorneys, as well as its geographic reach.
  • “We are excited to welcome Andrew to the firm,” said Grant S. Palmer , Blank Rome’s Chair and Managing Partner.

Fish & Richardson Welcomes Nine Lateral Litigation Associates

Retrieved on: 
Thursday, August 17, 2023

Fish & Richardson has welcomed nine lateral associates to the litigation practice group since the start of 2023.

Key Points: 
  • Fish & Richardson has welcomed nine lateral associates to the litigation practice group since the start of 2023.
  • "I am thrilled to see our firm continue to grow and foster new talent,” said Corrin Drakulich, Fish’s Global Head of Litigation.
  • She has experience in nearly all phases of litigation, from due diligence and pre-filing investigation through trial and post-trial motions.
  • Brandon’s background is in complex intellectual property litigation involving manufacturing, chemicals, life sciences, biosimilars, and pharmaceuticals (including Hatch-Waxman litigation).

HCW Biologics is Granted Third Fundamental Patent: U.S. Patent for Methods of Treating Age-Related Disorders

Retrieved on: 
Wednesday, June 14, 2023

The patent also includes methods of use claims for killing or reducing the number of senescent cells by administering HCW9218 in subjects with cancer.

Key Points: 
  • The patent also includes methods of use claims for killing or reducing the number of senescent cells by administering HCW9218 in subjects with cancer.
  • Senescence is considered a physiologic process that is important in promoting wound healing, regeneration, and many other vital functions.
  • The U.S. Patent and Trademark Office recognized the methods of treating cancer using the novel immunotherapeutic, HCW9218.
  • This method of use patent will support a previously issued patent, U.S. Patent No.

Accenture Recognizes Three Law Firms With Outside Counsel Diversity Award

Retrieved on: 
Tuesday, May 16, 2023

Accenture (NYSE: ACN) has recognized three law firms—Baker McKenzie, Fish & Richardson and Mayer Brown—with its Outside Counsel Diversity Award.

Key Points: 
  • Accenture (NYSE: ACN) has recognized three law firms—Baker McKenzie, Fish & Richardson and Mayer Brown—with its Outside Counsel Diversity Award.
  • The annual award celebrates firms working with Accenture that are making significant progress in inclusion, diversity and equity.
  • “We believe that all our partners can realize opportunities to make significant contributions to advancing inclusion, diversity and equity—in their own firms and in the legal profession as a whole.”
    The Accenture Outside Counsel Diversity Award recognizes the outstanding efforts of these law firms:
    Baker McKenzie is being honored with this award for the second consecutive year and continues to be a champion for diversity in the legal profession.
  • The firm prioritizes gender diversity in response to how women are historically underrepresented in its primary focus area of patent law.

Fish & Richardson Names Joshua A. Griswold as Managing Principal of Dallas Office

Retrieved on: 
Tuesday, March 14, 2023

Fish & Richardson Principal Joshua A. Griswold has been named the managing principal of the firm’s Dallas office .

Key Points: 
  • Fish & Richardson Principal Joshua A. Griswold has been named the managing principal of the firm’s Dallas office .
  • The Dallas office — one of three Fish locations in Texas — houses 46 intellectual property attorneys and technology specialists.
  • View the full release here: https://www.businesswire.com/news/home/20230314005810/en/
    Joshua A. Griswold, managing principal of Fish & Richardson's Dallas office (Photo: Business Wire)
    "I am delighted that Josh is stepping into the role of office managing principal," said John C. Adkisson , president and CEO of Fish.
  • "For 20 years, Josh has been a critical presence in the Dallas office, and I know that Josh will continue to cultivate a collaborative culture that is synonymous with Fish.